股市必读：山河药辅（300452）2月4日主力资金净流入1290.58万元

Group 1 - The stock price of Shanhe Pharmaceutical Excipients Co., Ltd. closed at 15.77 yuan on February 4, 2026, with an increase of 2.8% and a trading volume of 175,500 shares, amounting to a transaction value of 275 million yuan [1] - On February 4, the net inflow of main funds was 12.91 million yuan, while retail investors experienced a net outflow of 24.74 million yuan, indicating a mixed sentiment among different investor groups [2] - The company successfully passed its first on-site inspection by the U.S. FDA from December 4 to December 5, 2025, confirming that its quality management system meets international standards, which is expected to facilitate expansion into the U.S. and other international markets [1][2] Group 2 - The successful FDA inspection is anticipated to positively impact the company's ability to replace imported pharmaceutical excipients in the domestic market [1] - The company has received the Establishment Inspection Report (EIR) from the FDA, marking a significant milestone in its quality management recognition [1]